BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Whitcomb DC. Better Biomarkers for Pancreatic Diseases. Pancreas 2015;44:1171-3. [PMID: 26465944 DOI: 10.1097/MPA.0000000000000550] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Miller MS, Allen P, Brentnall TA, Goggins M, Hruban RH, Petersen GM, Rao CV, Whitcomb DC, Brand RE, Chari ST, Klein AP, Lubman DM, Rhim AD, Simeone DM, Wolpin BM, Umar A, Srivastava S, Steele VE, Rinaudo JA. Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report. Pancreas. 2016;45:1080-1091. [PMID: 27518363 DOI: 10.1097/mpa.0000000000000705] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
2 Staudacher JJ, Yazici C, Carroll T, Bauer J, Pang J, Krett N, Xia Y, Wilson A, Papachristou G, Dirmeier A, Kunst C, Whitcomb DC, Fantuzzi G, Jung B. Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target. Sci Rep 2017;7:12786. [PMID: 28986573 DOI: 10.1038/s41598-017-13000-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Steinkohl E, Olesen SS, Hansen TM, Drewes AM, Frøkjær JB. T1 relaxation times and MR elastography-derived stiffness: new potential imaging biomarkers for the assessment of chronic pancreatitis. Abdom Radiol (NY) 2021;46:5598-608. [PMID: 34524501 DOI: 10.1007/s00261-021-03276-5] [Reference Citation Analysis]
4 Greer JB, Greer P, Sandhu BS, Alkaade S, Wilcox CM, Anderson MA, Sherman S, Gardner TB, Lewis MD, Guda NM, Muniraj T, Conwell D, Cote GA, Forsmark CE, Banks PA, Tang G, Stello K, Gelrud A, Brand RE, Slivka A, Whitcomb DC, Yadav D. Nutrition and Inflammatory Biomarkers in Chronic Pancreatitis Patients. Nutr Clin Pract 2019;34:387-99. [PMID: 30101991 DOI: 10.1002/ncp.10186] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Whitcomb DC;  North American Pancreatitis Study Group. Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist With Topic Reviews, Updates, and Use Primers. Clin Transl Gastroenterol. 2019;10:e00027. [PMID: 31166201 DOI: 10.14309/ctg.0000000000000027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 15.5] [Reference Citation Analysis]
6 Whitcomb DC. Peering Into the "Black Box" of the Complex Chronic Pancreatitis Syndrome. Pancreas 2016;45:1361-4. [PMID: 27748718 DOI: 10.1097/MPA.0000000000000715] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]